Manage chronic hand eczema with conventional treatments, but emerging therapies show promise.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 146, doi. 10.1007/s40267-025-01155-3
- By:
- Publication type:
- Article
Works matching IS 11720360 AND DT 2025 AND VI 41 AND IP 4
Results: 7
1
2
Treat metabolic diseases with effective and approved therapies while new treatments are under investigation.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 151, doi. 10.1007/s40267-025-01154-4
- By:
- Publication type:
- Article
3
Iptacopan in paroxysmal nocturnal haemoglobinuria: a profile of its use.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 127, doi. 10.1007/s40267-025-01151-7
- By:
- Publication type:
- Article
4
Dose rounding: a cost-savings fix or the new standard?
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 157, doi. 10.1007/s40267-025-01150-8
- By:
- Publication type:
- Article
5
Take a personalised approach when treating older adults with rosacea.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 141, doi. 10.1007/s40267-025-01147-3
- By:
- Publication type:
- Article
6
Consider topical superpotent corticosteroids for oral lichen planus; reserve systemic therapy for severe disease.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 135, doi. 10.1007/s40267-025-01146-4
- By:
- Publication type:
- Article
7
Effective drug dosage rounding reduces healthcare expenses in the Japanese healthcare system.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 160, doi. 10.1007/s40267-025-01144-6
- By:
- Publication type:
- Article